Stereotactic ablative radiotherapy for the comprehensive treatment of 1-3 Oligometastatic tumors (SABR-COMET-3): study protocol for a randomized phase III trial.
Robert J OlsonLindsay MathewsMitchell LiuDevin SchellenbergBenjamin MouTanya BerrangStephen HarrowRohann J M CorreaVasudeva BhatHoward PaiIslam MohamedStacy MillerFamke SchneidersJoanna LabaDerek WilkeSashendra SenthiAlexander V LouieAnand SwaminathAnthony ChalmersStewart GaedeAndrew WarnerTanja D de GruijlAlison AllanDavid A PalmaPublished in: BMC cancer (2020)
Clinicaltrials.gov identifier: NCT03862911. Date of registration: March 5, 2019.